We then evaluated tumor specific CD8+ PD-1+ GP33+ T cells and again found a significant increase in tumor 1 and tumor 2 following combination treatment compared to untreated or monotherapy (Fig. 1c, d). The gene discussed is PDCD1; the disease is neoplasm.